# Quantum Biopharma Ltd.: Form 6-K, filed Jun 2, 2026

- Company: [Quantum Biopharma Ltd.](/companies/qntm.md) (CIK 1771885)
- Form: 6-K
- Filed: 2026-06-02
- Accepted by EDGAR: Jun 2, 2026, 11:50 ET
- Period: 2026-06-02
- Accession: 0001185185-26-002283
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1771885/000118518526002283/qntm6k060226.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1771885/000118518526002283/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1771885/000118518526002283/qntm6k060226.htm

Filed Jun 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001185185-26-002283. Last ingested by Listed: Nov 5, 2026, 19:55 ET. No prices; not investment advice.